Report Categories
View AllRecent Articles
View All
Halozyme Therapeutics HALO revenue climbs 375 YoY despite steep earnings miss investors parse guidance amid cost concerns
Drill Tools DTI Competitive Landscape Q4 2025 EPS Exceeds Expectations
What Wall Street expects from Nuveen NXP this quarter NXP Q2 2025 Nuveen TaxFree Income Portfolio Reports Q2 Results
What Marex MRX disclosed about workforce costs Q4 2025 Better Than Expected
CHS Pref B CHSCN Stock Volume Drought Flat 20260418
Cloudflare NET Profitability Outlook Cloudflare Inc beats EPS on strong AI cloud growth
Market Wrap Technology leads broad market gains as consumer sector lags
DTI Drilling Tools International Corporation Q4 2025 earnings beat expectations shares climb 55 percent on bullish investor sentiment
CTMX CytomX Therapeutics Inc shares climb over 7 percent despite wider than expected Q4 2025 per share losses
Royalty RMCO Stock Entry Timing Smart Money Active 20260418